Barta et al developed a prognostic score for a patient with AIDS-related lymphoma (ARL) based on the International Prognostic Index (IPI). This is based on data since the introduction of rituximab. The authors are from multiple hospitals in the United States and Europe.
Patient selection: malignant lymphoma in an HIV-positive patient